A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

E Felip; S Popat; U. Dafni; Karin Ribi; A. Pope; S. Cedres; R. Shah; F. de Marinis; L. Cove Smith; R. Bernabé; M. Früh; K. Nackaerts; L. Greillier; A. Scherz; B. Massuti; E. Nadal; L. Vila Martinez; T. Talbot; H. Roschitzki-Voser; G. Dimopoulou; S. Schär; B. Ruepp; S. Savic; S. Peters; R.A. Stahel

doi:10.1016/j.annonc.2024.12.014

A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

E Felip
, S Popat
, U. Dafni
, Karin Ribi
, A. Pope
, S. Cedres
, R. Shah
, F. de Marinis
, L. Cove Smith
, R. Bernabé
, M. Früh
, K. Nackaerts
, L. Greillier
, A. Scherz
, B. Massuti
, E. Nadal
, L. Vila Martinez
, T. Talbot
, H. Roschitzki-Voser
, G. Dimopoulou

S. Schär, B. Ruepp, S. Savic, S. Peters, R.A. Stahel

Careum Hochschule Gesundheit

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Aufsatznummer	5
Seiten (von - bis)	548
Seitenumfang	560
Fachzeitschrift	Annals of Oncology
Ausgabenummer	36
DOIs	https://doi.org/10.1016/j.annonc.2024.12.014
Publikationsstatus	Veröffentlicht - 2025

Zugriff auf Dokument

10.1016/j.annonc.2024.12.014

Dieses zitieren

Felip, E., Popat, S., Dafni, U., Ribi, K., Pope, A., Cedres, S., Shah, R., de Marinis, F., Cove Smith, L., Bernabé, R., Früh, M., Nackaerts, K., Greillier, L., Scherz, A., Massuti, B., Nadal, E., Vila Martinez, L., Talbot, T., Roschitzki-Voser, H., ... Stahel, R. A. (2025). A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial. Annals of Oncology, (36), 548. Artikel 5. https://doi.org/10.1016/j.annonc.2024.12.014

@article{e60b921358a74e02b659c375f49c1fa6,

title = "A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial",

author = "E Felip and S Popat and U. Dafni and Karin Ribi and A. Pope and S. Cedres and R. Shah and \{de Marinis\}, F. and \{Cove Smith\}, L. and R. Bernab{\'e} and M. Fr{\"u}h and K. Nackaerts and L. Greillier and A. Scherz and B. Massuti and E. Nadal and \{Vila Martinez\}, L. and T. Talbot and H. Roschitzki-Voser and G. Dimopoulou and S. Sch{\"a}r and B. Ruepp and S. Savic and S. Peters and R.A. Stahel",

year = "2025",

doi = "10.1016/j.annonc.2024.12.014",

language = "English",

pages = "548",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "36",

}

Felip, E, Popat, S, Dafni, U, Ribi, K, Pope, A, Cedres, S, Shah, R, de Marinis, F, Cove Smith, L, Bernabé, R, Früh, M, Nackaerts, K, Greillier, L, Scherz, A, Massuti, B, Nadal, E, Vila Martinez, L, Talbot, T, Roschitzki-Voser, H, Dimopoulou, G, Schär, S, Ruepp, B, Savic, S, Peters, S & Stahel, RA 2025, 'A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial', Annals of Oncology, Nr. 36, 5, S. 548. https://doi.org/10.1016/j.annonc.2024.12.014

A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial. / Felip, E; Popat, S; Dafni, U. et al.
in: Annals of Oncology, Nr. 36, 5, 2025, S. 548.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

AU - Felip, E

AU - Popat, S

AU - Dafni, U.

AU - Ribi, Karin

AU - Pope, A.

AU - Cedres, S.

AU - Shah, R.

AU - de Marinis, F.

AU - Cove Smith, L.

AU - Bernabé, R.

AU - Früh, M.

AU - Nackaerts, K.

AU - Greillier, L.

AU - Scherz, A.

AU - Massuti, B.

AU - Nadal, E.

AU - Vila Martinez, L.

AU - Talbot, T.

AU - Roschitzki-Voser, H.

AU - Dimopoulou, G.

AU - Schär, S.

AU - Ruepp, B.

AU - Savic, S.

AU - Peters, S.

AU - Stahel, R.A.

PY - 2025

Y1 - 2025

U2 - 10.1016/j.annonc.2024.12.014

DO - 10.1016/j.annonc.2024.12.014

M3 - Article

SN - 0923-7534

SP - 548

JO - Annals of Oncology

JF - Annals of Oncology

IS - 36

M1 - 5

ER -